Chris Torrance is the founder of PhoreMost. PhoreMost has raised $94M in total funding. Latest round: Seed. Backed by Amadeus Capital, Cambridge Enterprise.
Dr. Chris Torrance is the founder and former CEO of PhoreMost, a Cambridge, UK-based life sciences company. The company focuses on identifying druggable targets for therapeutics, particularly in oncology and inflammation. He was a co-investor in PhoreMost's initial $3.8 million seed round.
Full founder directory · Investor directory · Company funding database · Fundraising library